Skip to main content

Table 2 Bivariate and multivariate analysis of factors associated with ever being tested for HIV among children and young adolescents in Akwa-Ibom state

From: Correlates of uptake of HIV testing among children and young adolescents in Akwa-Ibom state, Nigeria: a secondary data analysis of the Akwa-Ibom aids indicator survey, 2017

 

Ever tested for HIV

Bivariate analysis

Multivariate analysis

n (%)

P value

AOR (95% C.I)a

P value

Child characteristics

 Age (years)

  < 1

40 (14.14)

 

1

 

  1–4

229 (17.20)

< 0.001*

1.22 (0.83–1.81)

0.308

  5–9

201 (13.79)

 

0.94 (0.60–1.47)

0.784

  10–14

98 (10.39)

 

0.72 (0.44–1.18)

0.187

 Sex

  Male

286 (14.09)

 

1

 

  Female

282 (14.21)

0.910

0.96 (0.79–1.17)

0.709

 Location

  Rural

341 (12.20)

 

1

 

  Urban

227 (18.33)

0.002*

1.11 (0.82–1.51)

0.500

 Ever transfused with blood

  No

538 (13.64)

 

1

 

  Yes

30 (46.11)

< 0.001*

5.33 (2.60–10.92)

< 0.001*

 Enrolled in school

  No

152 (14.29)

 

1

 

  yes

416 (14.10)

0.882

1.11 (0.83–1.49)

0.484

Caregiver characteristics

 Age (years)

  15–24

51 (12.75)

 

1

 

  25–34

228 (16.40)

< 0.001*

1.08 (0.72–1.61)

0.700

  35–44

203 (16.30)

 

1.37 (0.87–2.15)

0.172

  ≥ 45

86 (8.70)

 

0.78 (0.46–1.33)

0.356

 Sex

  Male

189 (12.79)

 

1

 

  Female

379 (14.90)

0.187

0.97 (0.71–1.31)

0.823

 Educational status

  None

16 (4.44)

 

1

 

  Primary

195 (12.03)

< 0.001*

2.22 (1.04–4.75)

0.039*

  Secondary

253 (15.33)

 

2.09 (1.00–4.41)

0.054

  Tertiary

104 (25.52)

 

2.67 (1.30–5.51)

0.008*

 Comprehensive knowledge of HIV

  No

355 (12.19)

 

1

 

  Yes

213 (19.21)

< 0.001*

1.22 (0.94–1.58)

0.133

 Caregiver ever tested for HIV

  No

57 (3.10)

 

1

 

  yes

511 (23.45)

< 0.001*

8.31 (5.67–12.19)

< 0.001*

  1. n(%) Unweighted frequency (weighted percentage), C.I Confidence interval, AOR Adjusted odds ratio
  2. *Significant (P < 0.05)
  3. aMeasure of the strength of association between selected factors and uptake of HIV testing